Astigmatism Treatment in India and UAE | Complete Patient Guide

• ELIGIBLE PATIENTS (Laser Refractive Surgery — LASIK / SMILE / PRK / Trans-PRK):

• Age ≥ 18 years with stable refraction (≤ 0.50 D change over 12 months)

• Corneal astigmatism: up to −6.00 D cylinder (LASIK/PRK); up to −3.00 D cylinder (SMILE)

• Adequate corneal thickness: minimum predicted residual stromal bed ≥ 250 µm post-ablation; preoperative central pachymetry ideally ≥ 500 µm

• Normal corneal topography with no posterior elevation irregularity, no forme fruste keratoconus, no ectasia risk factors

• Stable tear film: TBUT ≥ 10 seconds, Schirmer I ≥ 10 mm/5 min; or optimised dry eye disease (DED) before proceeding

• Pupils: mesopic pupil diameter considered relative to optical zone size to minimise dysphotopsia

• ELIGIBLE PATIENTS (Phakic IOL — EVO+ ICL with Toric Option):

• Age 21–45 years, anterior chamber depth ≥ 3.0 mm (Artisan/Verisyse) or vault-predicted by online calculator (EVO+)

• Astigmatism too high for laser (> −6.00 D) or cornea too thin for safe ablation

• Endothelial cell count ≥ 2,000 cells/mm²

• ELIGIBLE PATIENTS (Toric IOL / Refractive Lens Exchange — RLE):

• Age ≥ 45 years with presbyopia, or any age with contraindication to laser surgery

• Significant lenticular astigmatism or mixed astigmatism not correctable by corneal laser alone

• REQUIRED PRE-OPERATIVE DIAGNOSTICS:

• Scheimpflug corneal tomography (Pentacam HR / Galilei G4): maps anterior and posterior corneal curvature, pachymetric progression index (PPI), Belin-Ambrosio Enhanced Ectasia Display (BAD-D score)

• Wavefront aberrometry (iDesign 2.0 / iTrace): measures higher-order aberrations (HOA), total coma, trefoil, spherical aberration

• Optical biometry (IOLMaster 700 / Lenstar 900): AL, K readings, ACD, LT for IOL power calculation (Barrett Toric Universal II formula)

• Specular microscopy: endothelial cell density and morphology (mandatory for ICL candidates)

• Slit-lamp biomicroscopy and dilated fundus examination: to exclude peripheral retinal pathology before any refractive procedure

• Dry eye panel: OSDI questionnaire, TBUT, Schirmer, meibomian gland imaging (LipiScan) if indicated

• Manifest and cycloplegic refraction: with cyclopentolate 1% to reveal latent hyperopia and true cylinder axis

• ABSOLUTE CONTRAINDICATIONS:

• Keratoconus (Grade II or above) — may be offered CXL ± topography-guided PRK protocol per Kanellopoulos

• Active autoimmune disease with corneal involvement (rheumatoid arthritis peripheral ulcerative keratitis, Sjögren's with severe DED)

• Unstable refraction (> 0.50 D change in 12 months)

• Pregnancy or breastfeeding (refraction instability; avoid elective refractive surgery)

• Uncontrolled glaucoma or IOP > 21 mmHg

• Endothelial cell count < 2,000 cells/mm² (ICL contraindication)

• Active ocular infection or corneal scarring involving the ablation zone

LASER REFRACTIVE SURGERY:

1. Topography-Guided LASIK (Contoura Vision / iDesign Advanced): The most advanced form of LASIK for astigmatism. Uses 22,000 corneal elevation data points (Contoura) to customise the excimer laser ablation profile to both refraction and corneal irregularity. The Wavelight EX500 excimer laser (500 Hz repetition rate, 1.4 mm flying-spot beam) completes a full ablation in under 10 seconds per dioptre. A femtosecond laser (Intralase iFS, Ziemer LDV Z8, or Zeiss Visumax) creates the corneal flap at a precisely programmed depth (90–110 µm). Clinical data from the FDA Contoura trial showed 30.7% of patients achieved UCVA better than their best spectacle-corrected visual acuity (BSCVA) pre-operatively — an unprecedented outcome. Recovery: functional vision within 24 hours; stable refraction by 4–6 weeks.

2. SMILE (Small Incision Lenticule Extraction) — Zeiss VisuMax 800: A flapless, one-step femtosecond laser procedure. The laser carves a refractive lenticule within the corneal stroma (intrastromal) and a surgeon extracts it through a 2–4 mm arcuate incision. Because no flap is created, corneal biomechanical integrity is superior, corneal nerve density recovers faster (reduced dry eye incidence), and there is no flap dislocation risk — making SMILE preferred for contact sport athletes and military/aviation personnel. Corrects sphere up to −10.00 D and cylinder up to −3.00 D (VisuMax 800 CE-marked parameters). Recovery: slightly slower UCVA gain than LASIK in week 1; equivalent by month 1.

3. Trans-PRK (Transepithelial Photorefractive Keratectomy) / Advanced Surface Ablation: A no-touch, single-step surface ablation using the Schwind Amaris 1050RS or Nidek EC-5000. The epithelium and stroma are ablated in one sequence without mechanical debridement. Preferred for thin corneas (< 500 µm central thickness) or flat corneas where flap creation is suboptimal. Requires mitomycin-C (MMC) 0.02% application for 20–30 seconds to suppress subepithelial haze in corrections > −4.00 D cylinder. Recovery: 3–5 days of discomfort while epithelium heals under a bandage contact lens; UCVA stabilises over 4–8 weeks.

LENS-BASED SURGERY:

4. Phakic ICL with Toric Correction (EVO+ Visian ICL, STAAR Surgical): A collamer lens is implanted in the posterior chamber (between the iris and crystalline lens) through a 2.8 mm temporal clear corneal incision. The EVO+ model has a central aqueous port eliminating the need for peripheral iridotomy. Toric ICL models correct cylinder up to −3.50 D with sphere up to −18.00 D. Implantation is reversible — an important advantage for patients who develop progressive keratoconus or require IOL surgery later. ICL vaulting is confirmed on anterior segment OCT at day 1; target vault 250–750 µm.

5. Refractive Lens Exchange (RLE) with Toric Premium IOL: The crystalline lens is removed via phacoemulsification (identical to cataract surgery technique) and replaced with a toric monofocal, toric EDOF (extended depth-of-focus), or toric trifocal IOL. Premium platforms include:

- AcrySof IQ Toric (Alcon): corrects up to +3.75 D cylinder at the IOL plane (≈ +2.57 D at the corneal plane)

- Tecnis Symfony Toric (J&J Vision): EDOF optics for intermediate and near vision with astigmatism correction

- AT LARA / LISA Toric (Zeiss): diffractive trifocal toric for full spectacle independence

IOL power is calculated using the Barrett Toric Universal II formula and intraoperative aberrometry (ORA SYSTEM / Callisto Eye) to verify toric axis alignment before the wound is sealed. Digital marker systems (Verion, Callisto) replace manual ink marking, reducing axis error to < 3°.

6. Corneal Cross-Linking (CXL) ± Topography-Guided PRK (Athens Protocol) for Keratoconus-Related Irregular Astigmatism: In patients with progressive keratoconus causing irregular astigmatism, accelerated CXL (iLink, 9 mW/cm², 10 minutes) halts ectasia progression by strengthening corneal collagen. The Athens Protocol combines same-session topography-guided PRK (limited tissue removal ≤ 50 µm) to regularise the corneal surface, followed immediately by CXL. This is the only evidence-based surgical approach that both treats the astigmatism optically and arrests the underlying disease.

COMPARATIVE TECHNOLOGY TABLE:

• Standard: Conventional LASIK (microkeratome flap, wavefront-optimised ablation) — adequate for simple myopic astigmatism but inferior precision vs topography-guided

• Advanced: Topography-Guided LASIK (Contoura / iDesign) — treats corneal irregularity beyond refraction

• Minimally Invasive / Flapless: SMILE VisuMax 800 — best biomechanical profile, preferred for dry eye risk patients

• Surface Ablation: Trans-PRK — safest for thin corneas, no mechanical instruments on cornea

• Lens-Based: Toric ICL (EVO+) — ideal for high astigmatism with thin corneas, fully reversible

• Lens-Based Permanent: RLE with toric trifocal IOL — eliminates both astigmatism and presbyopia permanently

PHASE 1 — REMOTE PRE-OPERATIVE CONSULTATION (4–6 weeks before travel):

• Patient uploads existing spectacle/contact lens prescription, any prior topography maps, and medical history to GAF Healthcare's secure portal

• A GAF-affiliated refractive surgeon reviews records and issues a preliminary suitability opinion within 48 hours

• If suitable, GAF coordinates the e-Medical Visa application (India) or UAE entry visa, and confirms the surgical centre and surgeon

• Patient is advised to discontinue soft contact lens wear for 2 weeks (rigid/gas-permeable lenses: 4–6 weeks) before arriving, to allow corneal topography to stabilise

PHASE 2 — ARRIVAL AND PRE-OPERATIVE WORKUP (Day 1–2):

• GAF airport transfer to hospital-adjacent accommodation; dedicated patient coordinator escorts patient

• Full diagnostic battery on Day 1: manifest + cycloplegic refraction, Pentacam HR tomography, wavefront aberrometry, specular microscopy, dry eye assessment, biometry, dilated fundus exam

• Surgeon consultation on Day 2: reviews all diagnostic data, confirms surgical plan, selects procedure type, obtains informed consent; anaesthesia consultation if lens-based surgery planned

• Pre-operative drops started (antibiotic + anti-inflammatory ± lubricant for dry eye optimisation)

PHASE 3 — SURGICAL DAY (Day 3):

• Laser procedures (LASIK/SMILE/Trans-PRK): Outpatient; total time in suite 20–30 minutes for both eyes; the laser active time itself is 20–90 seconds per eye depending on correction magnitude

• Toric ICL implantation: Outpatient or 4-hour observation; performed under topical anaesthesia (proxymetacaine drops); bimanual intraocular surgery; no sutures required

• RLE with toric IOL: Day-case surgery; sequential bilateral (BIOL) or second eye 1–2 days later; phacoemulsification + IOL implantation takes 10–15 minutes per eye under topical anaesthesia

• Post-procedure rest in recovery for 1–2 hours; protective eyewear fitted; discharge instructions provided

PHASE 4 — EARLY POST-OPERATIVE PERIOD (Day 1–7):

• Day 1 post-op: mandatory slit-lamp review (LASIK: flap position, epithelial integrity; SMILE: lenticule bed; ICL: vault measurement on AS-OCT; RLE: IOL position, wound seal, IOP)

• Laser patients: UCVA often 6/9 to 6/6 by Day 1; photophobia and glare resolve over 48–72 hours

• PRK/Trans-PRK: bandage contact lens removed Day 3–5 when epithelium is confirmed healed; mild discomfort managed with oral NSAID and cold compresses

• ICL/RLE patients: IOP monitoring on Days 1, 3, and 7 to rule out pupillary block or steroid-response elevation

• Topical antibiotic (moxifloxacin 0.5% QID) + steroid (prednisolone acetate 1% or fluorometholone 0.1%) prescribed per protocol (typically 1–4 weeks depending on procedure)

PHASE 5 — FIT-TO-FLY REVIEW (Day 7–14):

• Confirmatory review: refraction, corneal topography, slit-lamp, IOP

• LASIK/SMILE: cleared to fly at Day 7 if IOP normal, flap/lenticule interface clear, UCVA ≥ 6/12

• Trans-PRK: cleared at Day 10–14 (epithelial healing and early stromal remodelling must be confirmed)

• ICL: cleared at Day 10–14 after vault stability confirmed on repeat AS-OCT

• RLE: cleared at Day 10–14 once both eyes have been operated and IOP is stable

• GAF provides a Fit-to-Fly medical certificate and a complete discharge summary with post-operative drop schedule for the home ophthalmologist

PHASE 6 — LONG-TERM RECOVERY (Months 1–12, at home):

• Month 1: Most patients fully spectacle-independent; corneal topography stabilising; residual higher-order aberrations diminishing

• Month 3: Final LASIK/SMILE refraction stable; PRK/Trans-PRK may still show slow remodelling to Month 6

• Month 6: Keratoconus/CXL patients: topography review to confirm ectasia arrest; slit-lamp for haze grading

• Month 12: Annual review recommended; ICL patients: biennial specular microscopy to monitor endothelial cell health

• GAF coordinates telemedicine follow-up appointments between the patient's home eye clinic and the treating surgeon